EUVIMEDEUVIMED entdecken
Crossref

GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma

Afaf T Ibrahiem, Sherine Refat, Khaled Elnaghi, Ziad Emarah, Reham Mohamed Nagib

Indian Journal of Pathology and Microbiology · 2024

DOI: 10.4103/ijpm.ijpm_78_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pathology and Microbiology, 2024. Verfasst von Afaf T Ibrahiem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Assistant Professor of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Amino Acid Transport System ASC, Glucose Transporter Type 1, Biomarkers, Tumor. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Investigation of new molecular markers expressed in colorectal carcinoma can help to select patients getting benefits from new target therapeutic modalities.

Aim

Investigation of expression of GLUT1 and ASCT2 in colorectal carcinoma. Materials and Methods: Sixty three colorectal resection specimens for cases diagnosed with colorectal carcinoma were included in the study. Full sections were examined for histopathological data including tumor type, grade, stage, and lymphovascular invasion were recorded. TMA blocks were constructed and immunostained with polyclonal antibodies for both GLUT1 and ASCT2.

Results

GLUT1 was expressed in 82% of cases while ASCT2 was expressed in 76% of cases. Statistically significant correlation was found between both GLUT1 and ASCT2. A statistically significant correlation was found between either marker with both disease stage and lymph node metastases. No significant correlation was found between either GLUT1 or ASCT2 and any of the clinical parameters as well as with disease-free survival.

Conclusion

GLUT1 and ASCT2 are more prevalent in poorly differentiated and advanced stage colorectal carcinoma. Their expression in high percentage of cases can suggest the possible role of their target therapies in colorectal carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAmino Acid Transport System ASCGlucose Transporter Type 1Biomarkers, TumorMinor Histocompatibility AntigensImmunohistochemistryHumansMaleFemalePrognosisMiddle AgedAgedAdultAged, 80 and over

Substanzen

Amino Acid Transport System ASCGlucose Transporter Type 1SLC1A5 protein, humanSLC2A1 protein, humanBiomarkers, TumorMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • Assistant Professor of Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Assistant Professor, Medical Oncology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Department of Oncology, King Abdullah Medical City, Makkah, Saudia Arabia.

Zitieren

APA

Ibrahiem, A. T., Refat, S., Elnaghi, K., Emarah, Z., & Nagib, R. M. (2024). GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_78_23

Vancouver

Ibrahiem AT, Refat S, Elnaghi K, Emarah Z, Nagib RM. GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma. Indian Journal of Pathology and Microbiology. 2024. doi:10.4103/ijpm.ijpm_78_23

BibTeX
@article{Ibrahiem2024,
  author = {Ibrahiem, Afaf T and Refat, Sherine and Elnaghi, Khaled and Emarah, Ziad and Nagib, Reham Mohamed},
  title = {GLUT1 and ASCT2 expression and their prognostic value in colorectal carcinoma},
  journal = {Indian Journal of Pathology and Microbiology},
  year = {2024},
  doi = {10.4103/ijpm.ijpm_78_23}
}
Kostenlos starten →